The authors concluded that implant survival rates in ectodermal dysplasia and tooth agenesis ranged between 88.5% and 100%. Implants in adolescent ectodermal dysplasia patients had no effect on craniofacial growth. Implants placed in patients younger than 18 years had higher failure rates. Multiple limitations in the review processes and included studies mean the conclusions may not be reliable.
Authors' objectives
To assess the effectiveness and optimal timing of dental implants in patients with ectodermal dysplasia syndrome and tooth agenesis.
Searching MEDLINE (1950 to present) , EMBASE (1966 to present) , EBM Reviews (The Cochrane Library, ACP Journal Club, DARE) were searched for English-only publications. Search terms were reported. Reference lists of identified articles were handsearched.
Study selection
All studies that evaluated dental implants in patients with ectodermal dysplasia and tooth agenesis were eligible for inclusion. Case reports were excluded. Details on eligible outcomes were not reported.
Included studies considered patients with ectodermal dysplasia and oligodontia or special needs. Mean age (incompletely reported) ranged from 11.2 to 55.6 years. Outcomes assessed included survival rates of implants, prosthesis complications, treatment costs and quality of life.
Study selection was done by one reviewer.
Assessment of study quality
The authors did not state that they assessed validity. The levels of evidence of selected studies were graded according to study designs: randomised controlled trials (level I); controlled clinical trials (level II); descriptive designs (level III); and expert opinions (level IV). Grading was done by one reviewer.
Data extraction
Data on levels of evidence, number of implants and outcome measures were extracted and summarised in a table.
The authors stated neither how the data were extracted for the review nor how many reviewers performed the data extraction.
